Comments: NH HB172 | 2024 | Regular Session
Bill Title: Relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.
Spectrum: Bipartisan Bill
Status: (Introduced) 2024-01-03 - Inexpedient to Legislate: Motion Adopted Voice Vote 01/03/2024 House Journal 1 P. 34 [HB172 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Bipartisan Bill
Status: (Introduced) 2024-01-03 - Inexpedient to Legislate: Motion Adopted Voice Vote 01/03/2024 House Journal 1 P. 34 [HB172 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2024 New Hampshire HB172 at this time. |